NCT03325101 2025-06-12Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable MelanomaMayo ClinicPhase 1/2 Terminated7 enrolled 11 charts
NCT03035331 2025-05-16Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin LymphomaMayo ClinicPhase 1/2 Completed11 enrolled 12 charts
NCT01853618 2019-12-10Tremelimumab With Chemoembolization or Ablation for Liver CancerNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed61 enrolled 18 charts